SpectraCure Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from SpectraCure
Access all reports
SpectraCure AB is a medical technology company that focuses on developing innovative cancer treatment systems. The company's primary technology involves interstitial photodynamic therapy (PDT), which uses laser light and photo-reactive drugs to treat solid cancer tumors. SpectraCure's proprietary system aims to provide a minimally invasive and highly precise treatment option, particularly for recurrent prostate cancer. The technology is designed to improve the quality of life for patients by targeting and eliminating deep-seated tumors. SpectraCure was founded in 2003 and is headquartered in Lund, Sweden. Its shares are listed on the Nasdaq Stockholm.
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
SPEC
Country
🇸🇪 Sweden